These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6459295)

  • 1. Impairment of in vitro generation of cytotoxic or T suppressor lymphocytes by Friend leukemia virus infection in mice.
    Garaci E; Migliorati G; Jezzi T; Bartocci A; Gioia L; Rinaldi C; Bonmassar E
    Int J Cancer; 1981 Sep; 28(3):367-73. PubMed ID: 6459295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of natural killer (nk) cell activity during FLV-P virus infection of mice.
    Migliorati G; Jezzi T; Frati L; Bonmassar E; Rossi GB; Garaci E; Riccardi C
    Int J Cancer; 1983 Jan; 31(1):81-90. PubMed ID: 6219962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
    Pettey CL; Collins JJ
    Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.
    Kumar V; Caruso T; Bennett M
    J Exp Med; 1976 Apr; 143(4):728-40. PubMed ID: 1082914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections.
    Genovesi EV; Marx PA; Wheelock EF
    J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Friend virus-induced immunodepression: effect of neuraminidase treatment on Thy-1.2 antigen expression and cytotoxic potential of splenocytes from virus-infected mice.
    Mascio AA; Ceglowski WS
    Infect Immun; 1978 Feb; 19(2):486-92. PubMed ID: 305416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse].
    Jezzi T; Premrov MG; Del Gobbo V; Garaci E
    Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037
    [No Abstract]   [Full Text] [Related]  

  • 9. Target cell heterogeneity in murine leukemia virus infection. II. Demonstration of Friend leukemia-virus-permissive and non-permissive subsets of splenic T cells.
    Isaak DD; Cerny J
    Int J Cancer; 1981; 27(4):505-12. PubMed ID: 6974139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the generation of secondary virus-specific proliferative and cytotoxic T lymphocytes by suppressor cells induced during primary anti-viral sensitization in vitro.
    Kreeb G; Creighton WD; Zinkernagel RM
    Immunology; 1981 May; 43(1):47-55. PubMed ID: 6454648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H; Kateley JR
    Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):538-44. PubMed ID: 6447123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. II. Infections of B and T cells with Friend virus complex indiffusion chambers and in vitro: effect of polyclonal mitogens.
    Cerny J; Hensgen PA; Fistel SH; Demler LM
    Int J Cancer; 1976 Aug; 18(2):189-96. PubMed ID: 1085288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements.
    Stukart MJ; Vos A; Melitef CJ
    Eur J Immunol; 1981 Mar; 11(3):251-7. PubMed ID: 6972310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of murine leukemia. VII. Prevention of Friend leukemia virus-induced immunosuppression by passive serum therapy.
    Genovesi EV; Livnat D; Collins JJ
    Int J Cancer; 1982 Nov; 30(5):609-24. PubMed ID: 6984021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
    Coppola MA; Green WR; Rich RF
    Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of suppressor T cells in culture--I. Cell-cell interactions.
    Ryoyama K; Ryoyama C; Ehrke MJ; Mihich E
    Int J Immunopharmacol; 1984; 6(5):509-20. PubMed ID: 6238913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.